American Portfolios Advisors Global Blood Therapeutics, Inc. Transaction History

American Portfolios Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Mar 22, 2023	BUY	$37.65 - $63.77 $1,882 - $3,188	50 New	50 $2.17 Million
Q3 2020 Mar 22, 2023	BUY	$52.76 - $74.49 $7,914 - $11,173	150 New	150 $8.27 Million
Q1 2020 Mar 24, 2023	BUY	$41.72 - $87.2 $1,043 - $2,180	25 New	25 $1.28 Million
Q4 2019 Mar 24, 2023	BUY	$45.7 - $81.86 $4,570 - $8,186	100 New	100 $7.95 Million
Q3 2019 Mar 24, 2023	SELL	$45.35 - $57.91 $680 - $868	-15 Reduced 5.88%	240 $11.6 Million
Q2 2019 Mar 24, 2023	BUY	$52.6 - $63.29 $13,413 - $16,138	255 New	255 $13.4 Million
Q1 2019 Mar 24, 2023	SELL	$39.99 - $53.48 $999 - $1,337	-25 Reduced 50.0%	25 $1.32 Million
Q4 2018 Mar 24, 2023	BUY	$31.54 - $46.67 $1,577 - $2,333	50 New	50 $2.05 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.